Lucinda Bateman: Difference between revisions
(added study) |
Notjusttired (talk | contribs) m (Text replacement - " author-link18=" to " author-link18 = ") |
||
(303 intermediate revisions by 4 users not shown) | |||
Line 2: | Line 2: | ||
'''Lucinda Bateman''' (Cindy Bateman), MD, is an [[ME/CFS]] physician and researcher. She founded and is Chief Medical Officer of the [[Bateman Horne Center]] of Excellence for ME/CFS and Fibromyalgia in Salt Lake City, Utah.<ref>https://batemanhornecenter.org/</ref> | '''Lucinda Bateman''' (Cindy Bateman), MD, is an [[ME/CFS]] physician and researcher. She founded and is Chief Medical Officer of the [[Bateman Horne Center]] of Excellence for ME/CFS and Fibromyalgia in Salt Lake City, Utah.<ref>https://batemanhornecenter.org/</ref> | ||
Dr. Bateman was one of the authors of the 2011 case definition, [[International Consensus Criteria]],<ref>{{Cite journal|last=Carruthers|first=Bruce M.| | Dr. Bateman was one of the authors of the 2011 case definition, [[International Consensus Criteria]],<ref>{{Cite journal|last = Carruthers | first = Bruce M. | authorlink = Bruce Carruthers | last2 = van de Sande | first2 = Marjorie I. | authorlink2 = Marjorie van de Sande | last3 = De Meirleir | first3 = Kenny L. | authorlink3 = Kenny De Meirleir | last4 = Klimas | first4 = Nancy G. | author-link4 = Nancy Klimas | last5 = Broderick | first5 = Gordon | author-link5 = Gordon Broderick | last6 = Mitchell | first6 = Terry | authorlink6 = Terry Mitchell | last7 = Staines | first7 = Donald | author-link7 = Donald Staines | last8 = Powles | first8 = A.C. Peter | authorlink8 = A C Peter Powles | last9 = Speight | first9 = Nigel | authorlink9 = Nigel Speight | last10 = Vallings | first10 = Rosamund | authorlink10 = Rosamund Vallings | last11 = Bateman | first11 = Lucinda | authorlink11 = Lucinda Bateman | last12 = Baumgarten-Austrheim | first12 = Barbara | authorlink12 = Barbara Baumgarten-Austrheim | last13 = Bell | first13 = David | author-link13 = David Bell | last14 = Carlo-Stella | first14 = Nicoletta | author-link14 = Nicoletta Carlo-Stella | last15 = Chia | first15 = John | author-link15 = John Chia | last16 = Darragh | first16 = Austin | author-link16 = Austin Darragh | last17 = Jo | first17 = Daehyun | author-link17 = Daehyun Jo | last18 = Lewis | first18 = Donald | author-link18 = Donald Lewis | last19 = Light | first19 = Alan | author-link19 = Alan Light | last20 = Marshall-Gradisnik | first20 = Sonya | author-link20 = Sonya Marshall-Gradisnik | last21 = Mena | first21 = Ismael | author-link21 = Ismael Mena | last22 = Mikovits | first22 = Judy | author-link22 = Judy Mikovits | last23 = Miwa | first23 = Kunihisa | author-link23 = Kunihisa Miwa | last24 = Murovska | first24 = Modra | author-link24 = Modra Murovska | last25 = Pall | first25 = Martin | author-link25 = Martin Pall | last26 = Stevens | first26 = Staci | author-link26 = Staci Stevens | date = 2011-08-22 | title=Myalgic encephalomyelitis: International Consensus Criteria|url=https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1365-2796.2011.02428.x|journal=Journal of Internal Medicine|language=en|volume=270|issue=4 | pages = 327–338|doi=10.1111/j.1365-2796.2011.02428.x|issn=0954-6820|pmc=3427890|pmid=21777306|via=}}</ref> and was one of the experts on the "Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome" that was convened for the 2015 [[Institute of Medicine report]].<ref>{{Cite book | title = Biographical Sketches of Committee Members, Consultants, and Staff|language=en | url =https://www.ncbi.nlm.nih.gov/books/NBK284904/ | date = 2015-02-10|publisher=National Academies Press (US)|last = Syndrome | first = Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue | last2 = Populations | first2 = Board on the Health of Select | last3 = Medicine | first3 = Institute of}}</ref> | ||
[[Suzanne Vernon]], PhD, the Research Liaison at [[Bateman Horne Center]] of Excellence works closely with Dr. Bateman on [[ME/CFS]] and [[fibromyalgia]] research.<ref>https://batemanhornecenter.org/suzanne-d-vernon-phd/</ref> | [[Suzanne Vernon]], PhD, the Research Liaison at [[Bateman Horne Center]] of Excellence works closely with Dr. Bateman on [[ME/CFS]] and [[fibromyalgia]] research.<ref>https://batemanhornecenter.org/suzanne-d-vernon-phd/</ref> | ||
==Awards== | ==Awards== | ||
*2016, Rudy Perpich Senior Lectureship Award, presented to a distinguished [[CFS]]/[[FMS]] scientist, physician or healthcare worker awarded by [[ | *2016, Rudy Perpich Senior Lectureship Award, presented to a distinguished [[Chronic fatigue syndrome|CFS]]/[[fibromyalgia|FMS]] scientist, physician or healthcare worker awarded by [[International Association for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis]]<ref>{{Cite web|url=https://www.iacfsme.org/iacfs-me-awardees | title = IACFS/ME Awardees|website= | ||
IACFS/ME|access-date=2020-04-23}}</ref> | |||
==Boards and committees== | ==Boards and committees== | ||
===CFSAC committee=== | ===CFSAC committee=== | ||
Dr. Bateman was a voting member of the [[Health and Human Services]]'s [[Chronic Fatigue Syndrome Advisory Committee]] for the terms 12/01/05 to 12/01/08<ref name="Nov, 2006" /> & 01/03/06 to 01/03/10<ref name="Spring, 2009" /> and | Dr. Bateman was a voting member of the [[Health and Human Services]]'s [[Chronic Fatigue Syndrome Advisory Committee]] for the terms 12/01/05 to 12/01/08<ref name="Nov, 2006" /> & 01/03/06 to 01/03/10<ref name="Spring, 2009" /> and was serving the term 12/13/2017 to Sep 2020 when the committee was dissolved by HHS.<ref>https://www.hhs.gov/ash/advisory-committees/cfsac/about-cfsac/roster/index.html</ref> | ||
=== Journal editoral board === | === Journal editoral board === | ||
Dr. Bateman serves on the editorial board of the journal, [[Fatigue: Biomedicine, Health & Behavior]].<ref>{{Cite web|url=https://www.tandfonline.com/action/journalInformation?show=editorialBoard&journalCode=rftg20&|title=Fatigue: Biomedicine, Health & Behavior|website= | Dr. Bateman serves on the editorial board of the journal, [[Fatigue: Biomedicine, Health & Behavior]].<ref>{{Cite web|url=https://www.tandfonline.com/action/journalInformation?show=editorialBoard&journalCode=rftg20& | title = Fatigue: Biomedicine, Health & Behavior | website = tandfonline.com|access-date=2019-11-01}}</ref> | ||
===ME/CFS Common Data Elements (CDE) Project=== | ===ME/CFS Common Data Elements (CDE) Project=== | ||
Member of the Pain Working Group of the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Common Data Element (CDE) Project sponsored by the [[National Institute of Neurological Disorders and Stroke]] and the [[Centers for Disease Control and Prevention]].<ref>{{Cite web|url=https://www.commondataelements.ninds.nih.gov/Myalgic%20Encephalomyelitis/Chronic%20Fatigue%20Syndrome#pane-138|title=Complete Myalgic Encephalomyelitis/Chronic Fatigue Syndrome CDE Roster|last=|first=|authorlink | Member of the Pain Working Group of the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Common Data Element (CDE) Project sponsored by the [[National Institute of Neurological Disorders and Stroke]] and the [[Centers for Disease Control and Prevention]].<ref>{{Cite web|url=https://www.commondataelements.ninds.nih.gov/Myalgic%20Encephalomyelitis/Chronic%20Fatigue%20Syndrome#pane-138 | title = Complete Myalgic Encephalomyelitis/Chronic Fatigue Syndrome CDE Roster | last = | first = | authorlink = | date = | website = NIH|archive-url=|archive-date=|url-status=|access-date=2019-10-11}}</ref> | ||
==Advocacy== | ==Advocacy== | ||
Line 27: | Line 28: | ||
=== Editorials === | === Editorials === | ||
* Aug 2019, Editorial: Advances in ME/CFS Research and Clinical Care<ref>{{Cite journal|last=Friedman|first=Kenneth| | * Aug 2019, Editorial: Advances in ME/CFS Research and Clinical Care<ref>{{Cite journal | last = Friedman | first = Kenneth | authorlink = Kenneth Friedman | last2 = Bateman | first2 = Lucinda | authorlink2 = Lucinda Bateman | last3 = Bested | first3 = Alison C. | authorlink3 = Alison Bested | last4 = Nahle | first4 = Zaher | authorlink4 = Zaher Nahle | date = Aug 2019 | title = Editorial: Advances in ME/CFS Research and Clinical Care|url=https://www.frontiersin.org/articles/10.3389/fped.2019.00370/full|journal=Frontiers in Pediatrics|volume=|issue=|pages=|doi=10.3389/fped.2019.00370|pmc=|pmid=|access-date=|quote=|via=}}</ref> - [https://www.frontiersin.org/articles/10.3389/fped.2019.00370/full (Partial text)] | ||
==Research studies== | ==Research studies== | ||
*2005, A team approach to treating [[CFS]]: Matching best medical practices to phases of illness.<ref>Fennell, P. A., & Bateman, L. (2005). "A team approach to treating CFS: Matching best medical practices to phases of illness." ''CFS Research Review'', Summer.</ref> | *2005, A team approach to treating [[Chronic fatigue syndrome|CFS]]: Matching best medical practices to phases of illness.<ref>Fennell, P. A., & Bateman, L. (2005). "A team approach to treating CFS: Matching best medical practices to phases of illness." ''CFS Research Review'', Summer.</ref> | ||
*2010, Severity of symptom flare after moderate [[exercise]] is linked to [[cytokine]] activity in [[chronic fatigue syndrome]]<ref>White, A.T., Light, A.R., Hughen, R.W., Bateman, L., Martins, T.B., Hill, H.R., and Light, K.C. (2010) Severity of symptom flare after moderate exercise is linked to cytokine activity in chronic fatigue syndrome. ''Psychophysiology'', 47(4):615-24. doi: 10.1111./j.1469-8986.2010.00978.x</ref> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4378647/ (Full Text)] | *2010, Severity of symptom flare after moderate [[exercise]] is linked to [[cytokine]] activity in [[chronic fatigue syndrome]]<ref>White, A.T., Light, A.R., Hughen, R.W., Bateman, L., Martins, T.B., Hill, H.R., and Light, K.C. (2010) Severity of symptom flare after moderate exercise is linked to cytokine activity in chronic fatigue syndrome. ''Psychophysiology'', 47(4):615-24. doi: 10.1111./j.1469-8986.2010.00978.x</ref> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4378647/ (Full Text)] | ||
*2011, Absence of [[XMRV]] retrovirus and other murine leukemia virus-related viruses in patients with [[chronic fatigue syndrome]]<ref>{{Cite journal|last=Shin|first=Clifford H.|last2=Bateman|first2=Lucinda| | *2011, Absence of [[XMRV]] retrovirus and other murine leukemia virus-related viruses in patients with [[chronic fatigue syndrome]]<ref>{{Cite journal|last = Shin | first = Clifford H. | last2 = Bateman | first2 = Lucinda | authorlink2 = Lucinda Bateman | last3 = Schlaberg | first3 = Robert | last4 = Bunker | first4 = Ashley M. | last5 = Leonard | first5 = Christopher J. | last6 = Hughen | first6 = Ronald W. | last7 = Light | first7 = Alan R. | authorlink7 = Alan Light | last8 = Light | first8 = Kathleen C | authorlink8 = Kathleen Light | last9 = Singh | first9 = Ila R. | date = Jul 2011 | title = Absence of XMRV retrovirus and other murine leukemia virus-related viruses in patients with chronic fatigue syndrome|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3126563/|journal=Journal of Virology|volume=85|issue=14 | pages = 7195-202|doi=10.1128/JVI.00693-11|via=}}</ref> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3126563/ (Full Text)] | ||
*2011, Evidence for a heritable predisposition to [[Chronic Fatigue Syndrome]]<ref name="Albright, 2011" /> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3128000/ (Full Text)] | *2011, Evidence for a heritable predisposition to [[Chronic Fatigue Syndrome]]<ref name="Albright, 2011" /> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3128000/ (Full Text)] | ||
*2012, A double-blind, placebo-controlled, randomized, clinical trial of the TLR-3 agonist [[rintatolimod]] in severe cases of chronic fatigue syndrome<ref name="Strayer, 2012" /> - [http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0031334 (Full Text)] | *2012, A double-blind, placebo-controlled, randomized, clinical trial of the TLR-3 agonist [[rintatolimod]] in severe cases of chronic fatigue syndrome<ref name="Strayer, 2012" /> - [http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0031334 (Full Text)] | ||
*2012, A Multicenter Blinded Analysis Indicates No Association between [[ME/CFS|Chronic Fatigue Syndrome/Myalgic Encephalomyelitis]] and either [[Xenotropic murine leukemia virus-related virus|Xenotropic Murine Leukemia Virus-Related Virus]] or Polytropic Murine Leukemia Virus<ref name="Alter, et al, 2012" /> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3448165/ (Full Text)] | *2012, A Multicenter Blinded Analysis Indicates No Association between [[ME/CFS|Chronic Fatigue Syndrome/Myalgic Encephalomyelitis]] and either [[Xenotropic murine leukemia virus-related virus|Xenotropic Murine Leukemia Virus-Related Virus]] or Polytropic Murine Leukemia Virus<ref name="Alter, et al, 2012" /> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3448165/ (Full Text)] | ||
*2012, Gene expression alterations at baseline and following moderate [[exercise]] in patients with [[Chronic Fatigue Syndrome]] and [[Fibromyalgia]] Syndrome<ref name="Light, 2012" /> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3175315/ (Full Text)] | *2012, Gene expression alterations at baseline and following moderate [[exercise]] in patients with [[Chronic Fatigue Syndrome]] and [[Fibromyalgia]] Syndrome<ref name="Light, 2012" /> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3175315/ (Full Text)] | ||
*2013, Differing [[leukocyte]] gene expression profiles associated with fatigue in patients with prostate cancer versus [[chronic fatigue syndrome]]<ref>Light | *2013, Differing [[leukocyte]] gene expression profiles associated with fatigue in patients with prostate cancer versus [[chronic fatigue syndrome]]<ref>{{Cite journal|last = Light | first = Kathleen C. | authorlink = Kathleen Light | last2 = Agarwal | first2 = Neeraj | authorlink2 = | last3 = Iacob | first3 = Eli | authorlink3 = | last4 = White | first4 = Andrea T. | authorlink4 = | last5 = Kinney | first5 = Anita Y. | authorlink5 = | last6 = VanHaitsma | first6 = Timothy A. | authorlink6 = | last7 = Aizad | first7 = Hannah | last8 = Hughen | first8 = Ronald W. | last9 = Bateman | first9 = Lucinda | authorlink9 = Lucinda Bateman | date = Dec 2013 | title = Differing leukocyte gene expression profiles associated with fatigue in patients with prostate cancer versus chronic fatigue syndrome|url=https://linkinghub.elsevier.com/retrieve/pii/S0306453013002977|journal=Psychoneuroendocrinology|language=en|volume=38|issue=12|pages=2983–2995|doi=10.1016/j.psyneuen.2013.08.008|pmc = 3848711|pmid=24054763|access-date=|quote=|via=}}</ref> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848711/ (Full Text)] | ||
*2014, No association found between the detection of either [[xenotropic murine leukemia virus-related virus]] or polytropic murine leukemia virus and [[chronic fatigue syndrome]] in a blinded, multi-site, prospective study by the establishment and use of the [[SolveCFS BioBank & Patient Registry|SolveCFS BioBank]]<ref>{{Cite journal|last=Irlbeck|first=David M.|last2=Vernon|first2=Suzanne D.| | *2014, No association found between the detection of either [[xenotropic murine leukemia virus-related virus]] or polytropic murine leukemia virus and [[chronic fatigue syndrome]] in a blinded, multi-site, prospective study by the establishment and use of the [[SolveCFS BioBank & Patient Registry|SolveCFS BioBank]]<ref>{{Cite journal|last = Irlbeck|first = David M. | last2 = Vernon | first2 = Suzanne D. | authorlink2 = Suzanne Vernon | last3 = McCleary | first3 = K. Kimberly | authorlink3 = Kim McCleary | last4 = Bateman | first4 = Lucinda | authorlink4 = Lucinda Bateman | last5 = Klimas | first5 = Nancy G. | authorlink5 = Nancy Klimas | last6 = Lapp | first6 = Charles W. | authorlink6 = Charles Lapp | last7 = Peterson | first7 = Daniel L. | authorlink7 = Daniel Peterson | last8 = Brown | first8 = James R. | last9 = Remlinger | first9 = Katja S.| date = 2014 | title = No association found between the detection of either xenotropic murine leukemia virus-related virus or polytropic murine leukemia virus and chronic fatigue syndrome in a blinded, multi-site, prospective study by the establishment and use of the SolveCFS BioBank | url =https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4236736/|journal=BMC Research Notes|volume=7 | pages = 461|doi=10.1186/1756-0500-7-461|via= | last10 = Wilfret | last11 = Gerondelis | first11 = Peter | first10 = David A.}}</ref> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4236736/ (Full Text)] | ||
*2015, Findings from a clinical and laboratory database developed for discovery of pathogenic mechanisms in [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]]<ref name="KlimasNG, 2015" /> - [http://www.tandfonline.com/doi/full/10.1080/21641846.2015.1023652 (Abstract)] | *2015, Findings from a clinical and laboratory database developed for discovery of pathogenic mechanisms in [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]]<ref name="KlimasNG, 2015" /> - [http://www.tandfonline.com/doi/full/10.1080/21641846.2015.1023652 (Abstract)] | ||
*2015, [[Chronic fatigue syndrome]] and co-morbid and consequent conditions: evidence from a multi-site clinical epidemiology study<ref name="BatemanL, 2015" /> - [http://www.tandfonline.com/doi/full/10.1080/21641846.2014.978109 (Abstract)] | *2015, [[Chronic fatigue syndrome]] and co-morbid and consequent conditions: evidence from a multi-site clinical epidemiology study<ref name="BatemanL, 2015" /> - [http://www.tandfonline.com/doi/full/10.1080/21641846.2014.978109 (Abstract)] | ||
* 2015, Distinct plasma immune signatures in ME/CFS are present early in the course of illness<ref>{{Cite journal|last1=Hornig|first1=M| | * 2015, Distinct plasma immune signatures in ME/CFS are present early in the course of illness<ref>{{Cite journal | last1 = Hornig | first1 = M | authorlink = Mady Hornig | last2 = Montoya | first2 = JG | authorlink2 = Jose Montoya | last3 = Klimas | first3 = NG | authorlink3 = Nancy Klimas | last4 = Levine | first4 = SM | authorlink4 = Susan Levine | last5 = Felsenstein | first5 = D | authorlink5 = Donna Felsenstein | last6 = Bateman | first6 = L | authorlink6=Lucinda Bateman | last7 = Peterson | first7 = DL | authorlink7 = Daniel Peterson | last8 = Gottschalk | first8 = CG | authorlink8 = Gunnar Gottschalk | last9 = Schultz|first9 = AF | authorlink9=Andrew Schultz | last10 = Che | first10 = X | authorlink10=Xiaoyu Che | last11 = Eddy | first11 = ML | authorlink11=Meredith Eddy | last12 = Komaroff | first12 = AL | authorlink12=Anthony Komaroff | last13 = Lipkin | first13 = WI | authorlink13 = Ian Lipkin | title = Distinct plasma immune signatures in ME/CFS are present early in the course of illness|journal=Science Advances|volume=1|issue=1 | page = | date = 2015 | pmid = |doi =10.1126/sciadv.1400121 | url = http://advances.sciencemag.org/content/1/1/e1400121.full}}</ref> - [https://advances.sciencemag.org/content/1/1/e1400121 (Full text)] | ||
*2016, Treatment of [[postural orthostatic tachycardia syndrome]] and management of [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]] following suspected West Nile virus infection<ref name="Baldwin, 2016" /> - [http://www.tandfonline.com/doi/full/10.1080/21641846.2016.1247971 (Abstract)] | *2016, Treatment of [[postural orthostatic tachycardia syndrome]] and management of [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]] following suspected West Nile virus infection<ref name="Baldwin, 2016" /> - [http://www.tandfonline.com/doi/full/10.1080/21641846.2016.1247971 (Abstract)] | ||
*2017, Multi-Site Clinical Assessment of [[ME/CFS|Myalgic Encephalomyelitis/Chronic Fatigue Syndrome]] (MCAM): Design and Implementation of a Prospective/Retrospective Rolling Cohort Study<ref name="Unger, 2017" /> - [https://www.ncbi.nlm.nih.gov/pubmed/28338983 (Abstract)] | *2017, Multi-Site Clinical Assessment of [[ME/CFS|Myalgic Encephalomyelitis/Chronic Fatigue Syndrome]] (MCAM): Design and Implementation of a Prospective/Retrospective Rolling Cohort Study<ref name="Unger, 2017" /> - [https://www.ncbi.nlm.nih.gov/pubmed/28338983 (Abstract)] | ||
Line 48: | Line 49: | ||
*2018, KPAX002 as a treatment for [[ME/CFS|Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)]]: A prospective, randomized trial<ref name="Montoya, 2018" /> - [http://www.ijcem.com/files/ijcem0065685.pdf (Full Text)] | *2018, KPAX002 as a treatment for [[ME/CFS|Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)]]: A prospective, randomized trial<ref name="Montoya, 2018" /> - [http://www.ijcem.com/files/ijcem0065685.pdf (Full Text)] | ||
*2018, Insights into [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]] phenotypes through comprehensive [[metabolomics]]<ref name="Nagy-Szakal, 2018" /> - [https://www.nature.com/articles/s41598-018-28477-9.pdf (Full Text)] | *2018, Insights into [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]] phenotypes through comprehensive [[metabolomics]]<ref name="Nagy-Szakal, 2018" /> - [https://www.nature.com/articles/s41598-018-28477-9.pdf (Full Text)] | ||
*2019, Estimating Prevalence, Demographics, and Costs of ME/CFS Using Large Scale Medical Claims Data and Machine Learning<ref>{{Cite journal|last=Proskauer|first=Charmian| | *2019, Estimating Prevalence, Demographics, and Costs of ME/CFS Using Large Scale Medical Claims Data and Machine Learning<ref>{{Cite journal | last = Proskauer | first = Charmian | authorlink = Charmian Proskauer | last2 = Rowe | first2 = Peter C. | authorlink2 = Peter Rowe | last3 = Lapp | first3 = Charles W. | authorlink3 = Charles Lapp | last4 = DeMaria | first4 = Alfred Jr | authorlink4 = | last5 = Bateman | first5 = Lucinda | authorlink5 = Lucinda Bateman | last6 = Attewell | first6 = John R. | last7 = Proskauer | first7 = Daniel | last8 = Kiernicki | first8 = David J. | last9 = Adebayo | first9 = Seyi | date = 2019 | title=Estimating Prevalence, Demographics, and Costs of ME/CFS Using Large Scale Medical Claims Data and Machine Learning | url =https://www.frontiersin.org/articles/10.3389/fped.2018.00412/full|journal=Frontiers in Pediatrics|language=English|volume=6|issue=|pages=|doi=10.3389/fped.2018.00412|issn=2296-2360|pmc=|pmid=30671425|quote=|via=}}</ref> - [https://www.frontiersin.org/articles/10.3389/fped.2018.00412/full (Full text)] | ||
* Aug 2019, Editorial: Advances in ME/CFS Research and Clinical Care<ref>{{Cite journal|last=Friedman|first=Kenneth| | * Aug 2019, Editorial: Advances in ME/CFS Research and Clinical Care<ref>{{Cite journal | last = Friedman | first = Kenneth | authorlink = Kenneth Friedman | last2 = Bateman | first2 = Lucinda | authorlink2 = Lucinda Bateman | last3 = Bested | first3 = Alison C. | authorlink3 = Alison Bested | last4 = Nahle | first4 = Zaher | authorlink4 = Zaher Nahle | date = Aug 2019 | title = Editorial: Advances in ME/CFS Research and Clinical Care|url=https://www.frontiersin.org/articles/10.3389/fped.2019.00370/full|journal=Frontiers in Pediatrics|volume=|issue=|pages=|doi=10.3389/fped.2019.00370|pmc=|pmid=|access-date=|quote=|via=}}</ref> - [https://www.frontiersin.org/articles/10.3389/fped.2019.00370/full (Full text)] | ||
* | * 2019, Pilot assessment of low NK cell-mediated ADCC and FCGR3A genetics in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): Based on inclusion of family members without ME/CFS as controls, low ADCC is unsuitable as a diagnostic biomarker<ref>{{Cite journal|last = Sung|first = Alexander P. | authorlink = | last2 = Tang | first2 = Jennifer J-J | authorlink2 = | last3 = Guglielmo | first3 = Michael J | authorlink3 = | last4 = Smith-Gagen | first4 = Julie | authorlink4 = | last5 = Bateman | first5 = Lucinda | authorlink5 = Lucinda Bateman | last6 = Redelman | first6 = Doug D. | authorlink6 = | last7 = Hudig | first7 = Dorothy | date = 2019-12-27 | title = Pilot assessment of low NK cell-mediated ADCC and FCGR3A genetics in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): Based on inclusion of family members without ME/CFS as controls, low ADCC is unsuitable as a diagnostic biomarker |url =http://medrxiv.org/lookup/doi/10.1101/2019.12.20.19015438|journal=MedRxIV|language=en|volume=|issue=|pages=|doi=10.1101/2019.12.20.19015438|pmc=|pmid=|access-date=|quote=|via=}}</ref> - [https://www.medrxiv.org/content/10.1101/2019.12.20.19015438v1 (Abstract)] | ||
* 2019, Perturbation of effector and regulatory [[T cell]] subsets in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)<ref>{{Cite journal | last = Karhan | first = Ece | last2 = Gunter | first2 = Courtney L | last3 = Ravanmehr | first3 = Vida | last4 = Horne | first4 = Meghan | last5 = Kozhaya | first5 = Lina | last6 = Renzullo | first6 = Stephanie | last7 = Placek | first7 = Lindsey | last8 = George | first8 = Joshy | last9 = Robinson | first9 = Peter N | last10 = Vernon | first10 = Suzanne D. | authorlink10 = Suzanne Vernon | last11 = Bateman | first11 = Lucinda | authorlink11 = Lucinda Bateman | last12 = Unutmaz | first12 = Derya | authorlink12 = Derya Unutmaz | date = 2019-12-26 | title = Perturbation of effector and regulatory T cell subsets in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)|journal=biorxiv|url=http://biorxiv.org/lookup/doi/10.1101/2019.12.23.887505|language=en|doi=10.1101/2019.12.23.887505}}</ref> - [https://www.biorxiv.org/content/10.1101/2019.12.23.887505v1.full (Full text)] | |||
*2020, Hemodynamics during the 10-minute NASA Lean Test: evidence of circulatory decompensation in a subset of ME/CFS patients<ref>{{Cite journal|last = Lee | first = Jihyun | authorlink = | last2 = Vernon | first2 = Suzanne D. | authorlink2 = Suzanne Vernon | last3 = Jeys | first3 = Patricia | authorlink3 = | last4 = Ali | first4 = Weam | authorlink4 = | last5 = Campos | first5 = Andrea | authorlink5 = | last6 = Unutmaz | first6 = Derya | authorlink6 = Derya Unutmaz | last7 = Yellman | first7 = Brayden | last8 = Bateman | first8 = Lucinda | authorlink8 = Lucinda Bateman | date = Dec 2020 | title = Hemodynamics during the 10-minute NASA Lean Test: evidence of circulatory decompensation in a subset of ME/CFS patients|url=https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-020-02481-y|journal=Journal of Translational Medicine|language=en|volume=18|issue=1 | pages = 314|doi=10.1186/s12967-020-02481-y|issn=1479-5876|pmc = 7429890|pmid=32799889|access-date=|quote=|via=}}</ref> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7429890/ (Full text)] | |||
*2021, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Essentials of Diagnosis and Management<ref name="Essentials2021">{{Cite journal | title = Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Essentials of Diagnosis and Management | date = 2021-11-01|url=https://www.sciencedirect.com/science/article/pii/S0025619621005139|journal=Mayo Clinic Proceedings|volume=96|issue=11|pages=2861–2878|last = Bateman | first = Lucinda | authorlink = Lucinda Bateman | last2 = Bested | first2 = Alison C. | authorlink2 = Alison Bested | last3 = Bonilla | first3 = Hector F. | authorlink3 = Hector Bonilla | last4 = Chheda | first4 = Bela V. | authorlink4 = Bela Chheda | last5 = Chu | first5 = Lily | authorlink5 = Lily Chu | last6 = Curtin | first6 = Jennifer M. | authorlink6 = | last7 = Dempsey | first7 = Tania T. | last8 = Dimmock | first8 = Mary E. | authorlink8 = Mary Dimmock | last9 = Dowell | first9 = Theresa G. | last10 = Felsenstein | first10 = Donna | last11 = Kaufman | first11 = David L. | authorlink11 = David Kaufman|language=en|doi=10.1016/j.mayocp.2021.07.004|pmc=|pmid=|access-date=|issn=0025-6196|quote=|via=}}</ref> - [https://www.sciencedirect.com/science/article/pii/S0025619621005139 (Full text)] | |||
==Clinic location== | ==Clinic location== | ||
Line 59: | Line 63: | ||
Salt Lake City, Utah 84102 | Salt Lake City, Utah 84102 | ||
1-801-359-7400 | [[Tel:1-801-359-7400|1-801-359-7400]] | ||
==Talks and interviews== | ==Talks and interviews== | ||
*9 | *Sep 9, 2014, [http://www.fcclinic.com/SLEEP%20research%20CDC%20talk%20090914%20final.pdf ''Can ME/CFS and FM Research Help You Sleep?''] | ||
*2015, [[Spoonie Radio]] Episode 10 Guest - Dr. Lucinda Bateman - [http://www.drcourtneycraig.com/blog/2015/5/6/spoonie-radio-ep-10-dr-lucinda-bateman Podcast and Full Text Transcript] | *2015, [[Spoonie Radio]] Episode 10 Guest - Dr. Lucinda Bateman - [http://www.drcourtneycraig.com/blog/2015/5/6/spoonie-radio-ep-10-dr-lucinda-bateman Podcast and Full Text Transcript] | ||
*2016, [https://www.youtube.com/watch?v=ru8o-n-u_Ts Simple But Effective Tools for Management of ME/CFS and FM - Lucinda Bateman, MD] | *2016, [https://www.youtube.com/watch?v=ru8o-n-u_Ts Simple But Effective Tools for Management of ME/CFS and FM - Lucinda Bateman, MD] | ||
*2016, [https://www.youtube.com/watch?v=kXTt_JFDQ5w&feature=em-subs_digest BHC Wings to Fly - Dr. Bateman] | *2016, [https://www.youtube.com/watch?v=kXTt_JFDQ5w&feature=em-subs_digest BHC Wings to Fly - Dr. Bateman] | ||
*2016, [http://iacfsme.org/Conferences/2016-Fort-Lauderdale/Agenda/Professional-Agenda.aspx 12th International IACFS/ME Biennial Clinical and Research Conference, Emerging Science and Clinical Care, Paper presentation:''Synergy Trial for CFS – a phase 2 study of low-dose methylphenidate plus mitochondrial support''] | *2016, [http://iacfsme.org/Conferences/2016-Fort-Lauderdale/Agenda/Professional-Agenda.aspx 12th International IACFS/ME Biennial Clinical and Research Conference, Emerging Science and Clinical Care, Paper presentation:''Synergy Trial for CFS – a phase 2 study of low-dose methylphenidate plus mitochondrial support''] | ||
*3-5 | *May 3-5, 2018, [[ME/CFS Canadian Collaborative Team Conference]] - Speech title: ''Objective Diagnosis of ME/CFS''<ref>{{Cite web|url=https://fourwaves-sots.s3.amazonaws.com/static/media/uploads/5FFGG5h0kBRlJTgexdugaQ%3D%3D/2018/04/24/me_cfs_final-program.pdf | title=ME/CFS Canadian Collaborative Team Conference program|last = | first = | authorlink = | date = | website = |archive-url=|archive-date=|url-status=|access-date=2019-03-06}}</ref> | ||
*Oct 23, 2021, [https://youtu.be/goPzV8U8MNU Clinical Perspective and Impact of Long Covid] | |||
==Webinars == | ==Webinars == | ||
Line 88: | Line 93: | ||
==Blog posts== | ==Blog posts== | ||
*17 | *October 17, 2016, [http://solvecfs.org/pearls-of-wisdom-from-an-mecfs-physician-part-1/ Pearls of Wisdom from an ME/CFS Physician, part 1] | ||
*17 | *October 17, 2016, [http://solvecfs.org/pearls-of-wisdom-from-an-mecfs-physician-part-2/ Pearls of Wisdom from an ME/CFS Physician, part 2] | ||
*17 | *October 17, 2016, [http://solvecfs.org/pearls-of-wisdom-from-a-cfs-physician-part-3/ Pearls of Wisdom from a CFS Physician, part 3] | ||
Line 109: | Line 114: | ||
==References== | ==References== | ||
<references> | <references> | ||
<ref name="Albright, 2011">{{Citation | <ref name="Albright, 2011">{{Citation | last1 = Albright | first1 = Frederick | authorlink1 = | last2 = Light | first2 = Kathleen | authorlink2 = Kathleen Light | last3 = Light | first3 = Alan | authorlink3 = Alan Light | last4 = Bateman | first4 = Lucinda | authorlink4 = Lucinda Bateman | last5 = Cannon-Albright | first5 = Lisa A | authorlink5 = | title = Evidence for a heritable predisposition to Chronic Fatigue Syndrome | journal = BMC Neurology | volume = 11 | issue = 62 | page = | date = 2011 | doi = 10.1186/1471-2377-11-62 }}</ref> | ||
| last1 | <ref name="Alter, et al, 2012">{{Citation | last1 = Alter | first1 = Harvey J. | authorlink1 = | last2 = Mikovits | first2 = Judy A. | authorlink2 = Judy Mikovits | last3 = Switzer | first3 = William M. | authorlink3 = | last4 = Ruscetti | first4 = Francis W. | authorlink4 = | last5 = Lo | first5 = Shyh-Ching | authorlink5 = | last6 = Klimas | first6 = Nancy | authorlink6 = Nancy Klimas | last7 = Komaroff | first7 = Anthony L. | authorlink7 = Anthony Komaroff | last8 = Montoya | first8 = Jose G. | authorlink8 = Jose Montoya | last9 =Bateman | first9 = Lucinda | authorlink9 = Lucinda Bateman | last10 = Levine | first10 = Susan | authorlink10 = Susan Levine | last11 = Peterson | first11 = Daniel | authorlink11 = Daniel Peterson | last12 = Levin | first12 = Bruce | authorlink12 = Bruce Levin | last13 = Hanson | first13 = Maureen R. | authorlink13 = Maureen Hanson | last14 = Genfi | first14 = Afia | authorlink14 = | last15 = Bhat | first15 = Meera | authorlink15 = | last16 = Zheng | first16 = HaoQiang | authorlink16 = | last17 = Wang | first17 = Richard | authorlink17 = | last18 = Li | first18 = Bingjie | authorlink18 = | last19 = Hung | first19 = Guo-Chiuan | authorlink19 = | last20 = Lee | first20 = Li Ling | authorlink20 = | last21 = Sameroff | first21 = Stephen | authorlink21 = | last22 = Heneine | first22 = Walid | authorlink22 = | last23 = Coffin | first23 = John | authorlink23 = | last24 = Hornig | first24 = Mady | authorlink24 = Mady Hornig | last25 = Lipkin | first25 = W. Ian | authorlink25 = Ian Lipkin | title = A Multicenter Blinded Analysis Indicates No Association between Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and either Xenotropic Murine Leukemia Virus-Related Virus or Polytropic Murine Leukemia Virus | journal = mBio | volume = 3 | issue = 5 | page = e00266–12 | date = 2012 | pmid = | doi = 10.1128/mBio.00266-12 }}</ref> | ||
| last2 | <ref name="Baldwin, 2016">{{Citation | last1 = Baldwin | first1 = Nicole L. | authorlink1 = | last2 = Murray | first2 = Kristy O. | authorlink2 = | last3 = Garcia | first3 = Melissa N. | authorlink3 = | last4 = Bateman | first4 = Lucinda | authorlink4 = Lucinda Bateman | title = Treatment of postural orthostatic tachycardia syndrome and management of myalgic encephalomyelitis/chronic fatigue syndrome following suspected West Nile virus infection | journal = Fatigue: Biomedicine, Health & Behavior | volume = 4 | issue = 4 | page = 226-236 | date = 2016 | doi = 10.1080/21641846.2016.1247971 }}</ref> | ||
| last3 | <ref name="BatemanL, 2015">{{Citation | last1 = Bateman | first1 = L. | authorlink1 = Lucinda Bateman | last2 = Darakjy | first2 = S. | authorlink2 = | last3 = Klimas | first3 = N. | authorlink3 = Nancy Klimas | last4 = Peterson | first4 = D. | authorlink4 = Daniel Peterson | last5 = Levine | first5 = S.M. | authorlink5 = Susan Levine | last6 = Allen | first6 = A. | authorlink6 = | last7 = Carlson | first7 = S.A. | authorlink7 = | last8 = Balbin | first8 = E.G. | authorlink8 = Elizabeth Balbin | last9 = Gottschalk | first9 = G. | authorlink9 = Gunnar Gottschalk | last10 = March | first10 = D. | authorlink10 = | title = Chronic fatigue syndrome and co-morbid and consequent conditions: evidence from a multi-site clinical epidemiology study | journal = Fatigue: Biomedicine, Health & Behavior | volume = 3 | issue = 1 | page = 1-15 | date = 2015 | pmid = | doi = 10.1080/21641846.2014.978109 }}</ref> | ||
| last4 | <ref name="KlimasNG, 2015">{{Citation | last1 = Klimas | first1 = N.G. | authorlink1 = Nancy Klimas | last2 = Ironson | first2 = G. | authorlink2 = | last3 = Carter | first3 = A. | authorlink3 = | last4 = Balbin | first4 = E. | authorlink4 = Elizabeth Balbin | last5 = Bateman | first5 = L. | authorlink5 = Lucinda Bateman | last6 =Felsenstein | first6 = D. | authorlink6 = Donna Felsenstein | last7 = Levine | first7 = S. | authorlink7 = Susan Levine | last8 = Peterson | first8 = D. | authorlink8 = Daniel Peterson | last9 =Chiu | first9 = K. | authorlink9 = | last10 = Allen | first10 = A. | authorlink10 = | last11 = Cunningham | first11 = K. | authorlink11 = | last12 = Gottschalk | first12 = C.G. | authorlink12 = Gunnar Gottschalk | last13 = Fletcher | first13 = M | authorlink13 = Mary Ann Fletcher | last14 = Hornig | first14 = M. | authorlink14 = Mady Hornig | last15 = Canning | first15 = C. | authorlink15 =| last16 = Komaroff | first16 = A.L. | authorlink16 = Anthony Komaroff | title = Findings from a clinical and laboratory database developed for discovery of pathogenic mechanisms in myalgic encephalomyelitis/chronic fatigue syndrome | journal = Fatigue: Biomedicine, Health & Behavior | volume = 3 | issue = 2 | page = 75-96 | date = 2015 | pmid = | doi = 10.1080/21641846.2015.1023652 }}</ref> | ||
| last5 | <ref name="Light, 2012">{{Citation | last1 = Light | first1 = Alan R | authorlink1 = Alan Light | last2 = Bateman | first2 = Lucinda | authorlink2 = Lucinda Bateman | last3 = Jo | first3 = Daehyun | authorlink3 = Daehyun Jo | last4 = Hughen | first4 = RW | authorlink4 = | last5 = Vanhaitsma | first5 = TA | authorlink5 = | last6 = White | first6 = AT | authorlink6 = | last7 = Light | first7 = Kathleen | authorlink7 = Kathleen Light | title = Gene expression alterations at baseline and following moderate exercise in patients with Chronic Fatigue Syndrome and Fibromyalgia Syndrome | journal = Journal of Internal Medicine | volume = 271 | issue = 1 | page = 64-81 | date = 2012 | pmid = | doi = 10.1111/j.1365-2796.2011.02405.x }}</ref> | ||
| title | <ref name="Montoya, 2018">{{Citation | last1 = Montoya | first1 = Jose G | authorlink1 = Jose Montoya | last2 = Anderson | first2 = Jill N | authorlink2 = | last3 = Adolphs | first3 = Danya L | authorlink3 = | last4 = Bateman | first4 = Lucinda| authorlink4 = Lucinda Bateman | last5 = Klimas | first5 = Nancy | authorlink5 = Nancy Klimas | last6 = Levine | first6 = Susan M | authorlink6 = Susan Levine | last7 = Garvert | first7 = Donn W | authorlink7 = | last8 = Kaiser | first8 = Jon D | authorlink8 = Jon Kaiser | title = KPAX002 as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A prospective, randomized trial | journal = International Journal of Clinical and Experimental Medicine | volume = 11 | issue = 3 | page = 2890-2900 | date = 2018 | pmid = | doi = | url = http://www.ijcem.com/files/ijcem0065685.pdf }}</ref> | ||
| journal = BMC Neurology | <ref name="Nagy-Szakal, 2017">{{Citation | last1 = Nagy-Szakal | first1 = Dorottya | authorlink1 = Dorottya Nagy-Szakal | last2 = Williams | first2 = Brent L. | authorlink2 = | last3 = Mishra | first3 = Nischay | authorlink3 = | last4 = Che | first4 = Xiaoyu | authorlink4 = | last5 = Lee | first5 = Bohyun | authorlink5 = | last6 = Bateman | first6 = Lucinda | authorlink6 = Lucinda Bateman | last7 = Klimas | first7 = Nancy G. | authorlink7 = Nancy Klimas | last8 = Komaroff | first8 = Anthony L. | authorlink8 = Anthony Komaroff | last9 = Levine | first9 = Susan | authorlink9 = Susan Levine | last10 = Montoya | first10 = Jose G. | authorlink10 = Jose Montoya | last11 = Peterson | first11 = Daniel L. | authorlink11 = Daniel Peterson | last12 = Ramanan | first12 = Devi | authorlink12 = | last13 = Jain | first13 = Komal | authorlink13 = | last14 = Eddy | first14 = Meredith L. | authorlink14 = | last15 = Hornig | first15 = Mady | authorlink15 = Mady Hornig | last16 = Lipkin | first16 = W. Ian | authorlink16 = Ian Lipkin | title = Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome | journal = Microbiome | volume = 5 | issue = 44 | page = | date = 2017 | pmid = | doi = 10.1186/s40168-017-0261-y }}</ref> | ||
| date | <ref name="Nagy-Szakal, 2018">{{Citation | last1 = Nagy-Szakal | first1 = Dorottya | authorlink1 = Dorottya Nagy-Szakal | last2 = Barupal | first2 = Dinesh K. | authorlink2 = | last3 = Lee | first3 = Bohyun | authorlink3 = | last4 = Che | first4 = Xiaoyu | authorlink4 = | last5 = Williams | first5 = Brent L. | authorlink5 = | last6 = Kahn | first6 = Ellie J. R. | authorlink6 = | last7 = Ukaigwe | first7 = Joy E. | authorlink7 = | last8 = Bateman | first8 = Lucinda | authorlink8 = Lucinda Bateman | last9 = Klimas | first9 = Nancy G. | authorlink9 = Nancy Klimas | last10 = Komaroff | first10 = Anthony L. | authorlink10 = Anthony Komaroff | last11 = Levine | first11 = Susan | authorlink11 = Susan Levine | last12 = Montoya | first12 = Jose G. | authorlink12 = Jose Montoya | last13 = Peterson | first13 = Daniel L. | authorlink13 = Daniel Peterson | last14 = Levin | first14 = Bruce | authorlink14 = Bruce Levin | last15 = Hornig | first15 = Mady | authorlink15 = Mady Hornig | last16 = Fiehn | first16 = Oliver | authorlink16 = | last17 = Lipkin | first17 = W. Ian | authorlink17 = Ian Lipkin | title = Insights into myalgic encephalomyelitis/chronic fatigue syndrome phenotypes through comprehensive metabolomics | journal = Scientific Reports | volume = 8 | issue = 1 | page = 10056 | date = 2018 | pmid = | doi = 10.1038/s41598-018-28477-9 }}</ref> | ||
| doi | <ref name="Nov, 2006">{{citation | author = HHS.gov | title = Nov 20 & 21, 2006 CFSAC Meeting | ||
}} | | type = Minutes | date = 2006 | url = http://wayback.archive-it.org/3919/20140324192930/http://www.hhs.gov/advcomcfs/meetings/minutes/cfsac061120min_pdf.pdf }}</ref> | ||
</ref> | <ref name="Spring, 2009">{{citation | author = HHS.gov | title = May 27 & 28, 2009 CFSAC Meeting | ||
<ref name="Alter, et al, 2012">{{Citation | | type = Roster | date = 2009 | url = http://wayback.archive-it.org/3919/20140324192913/http://www.hhs.gov/advcomcfs/meetings/minutes/cfsac052709min.pdf }}</ref> | ||
| last1 | <ref name="Strayer, 2012">{{Citation | last1 = Strayer | first1 = DR | authorlink1 = David Strayer | last2 = Carter | first2 = WA | authorlink2 = William Carter | last3 = Stouch | first3 = BC | authorlink3 = | last4 = Stevens | first4 = SR | authorlink4 = Staci Stevens | last5 = Bateman | first5 = L | authorlink5 = Lucinda Bateman | last6 = Cimoch | first6 = PJ | authorlink6 = | last7 = Lapp | first7 = CW | authorlink7 = Charles Lapp | last8 = Peterson | first8 = DL | authorlink8 = Daniel Peterson | last9 =Chronic Fatigue Syndrome AMP-516 Study Group | authorlink9 = | last10 = Mitchell | first10 = WM | authorlink10 = William Mitchell | title = A double-blind, placebo-controlled, randomized, clinical trial of the TLR-3 agonist rintatolimod in severe cases of chronic fatigue syndrome. | journal = PLoS One | volume = 7 | issue = 3 | page = e31334 | date = 2012 | pmid = 22431963 | doi = 10.1371/journal.pone.0031334 }}</ref> | ||
| last2 | <ref name="Unger, 2017">{{Citation | last1 = Unger | first1 = Elizabeth R. | authorlink1 = Elizabeth Unger | last2 = Lin | first2 = Jin-Mann S. | authorlink2 = Jin-Mann Sally Lin | last3 = Tian | first3 = Hao | authorlink3 = | last4 = Natelson | first4 = Benjamin H | authorlink4 = Benjamin Natelson | last5 = Lange | first5 = Gudrun | authorlink5 = Gudrun Lange | last6 = Vu | first6 = Diana | authorlink6 = | last7 = Blate | first7 = Michelle | authorlink7 = | last8 = Klimas | first8 = Nancy G. | authorlink8 = Nancy Klimas | last9 =Balbin | first9 = Elizabeth G. | authorlink9 = Elizabeth Balbin | last10 = Bateman | first10 = Lucinda | authorlink10 = Lucinda Bateman | last11 = Allen | first11 = Ali | authorlink11 = | last12 = Lapp | first12 = Charles W. | authorlink12 = Charles Lapp | last13 = Springs | first13 = Wendy | authorlink13 = | last14 = Kogelnik | first14 = Andreas M. | authorlink14 = Andreas Kogelnik | last15 = Phan | first15 = Catrina C. | authorlink15 = | last16 = Danver | first16 = Joan | authorlink16 = | last17 = Podell | first17 = Richard N. | authorlink17 = Richard Podell | last18 = Fitzpatrick | first18 = Trisha | authorlink18 = | last19 = Peterson | first19 = Daniel L. | authorlink19 = Daniel Peterson | last20 = Gottschalk | first20 = C. Gunnar | authorlink20 = Gunnar Gottschalk | last21 = Rajeevan | first21 = Mangalathu S. | authorlink21 = Mangalathu Rajeevan | last22 = MCAM Study Group | title = Multi-Site Clinical Assessment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (MCAM): Design and Implementation of a Prospective/Retrospective Rolling Cohort Study. | journal = American Journal of Epidemiology | volume = 1-10 | issue = | page = | date = 2017 | pmid = | doi = 10.1093/aje/kwx029 }}</ref> | ||
| last3 | |||
| last4 | |||
| last5 | |||
| last6 | |||
| last7 | |||
| last8 | |||
| last9 | |||
| last10 | |||
| last11 | |||
| last12 | |||
| last13 | |||
| last14 | |||
| last15 | |||
| last16 | |||
| last17 | |||
| last18 | |||
| last19 | |||
| last20 | |||
| last21 | |||
| last22 | |||
| last23 | |||
| last24 | |||
| last25 | |||
| title | |||
| journal = mBio | |||
| date | |||
| pmid | |||
| doi | |||
}} | |||
</ref> | |||
<ref name="Baldwin, 2016">{{Citation | |||
| last1 | |||
| last2 | |||
| last3 | |||
| last4 | |||
| title | |||
| journal = Fatigue: Biomedicine, Health & Behavior | |||
| date | |||
| doi | |||
}} | |||
</ref> | |||
<ref name="BatemanL, 2015">{{Citation | |||
| last1 | |||
| last2 | |||
| last3 | |||
| last4 | |||
| last5 | |||
| last6 | |||
| last7 | |||
| last8 | |||
| last9 | |||
| last10 | |||
| title | |||
| journal = Fatigue: Biomedicine, Health & Behavior | volume = 3 | |||
| date | |||
| pmid | |||
| doi | |||
}} | |||
</ref> | |||
<ref name="KlimasNG, 2015">{{Citation | |||
| last1 | |||
| last2 | |||
| last3 | |||
| last4 | |||
| last5 | |||
| last6 | |||
| last7 | |||
| last8 | |||
| last9 | |||
| last10 | |||
| last11 | |||
| last12 | |||
| last13 | |||
| last14 | |||
| last15 | |||
| last16 | |||
| title | |||
| journal = Fatigue: Biomedicine, Health & Behavior | |||
| date | |||
| pmid | |||
| doi | |||
}} | |||
</ref> | |||
<ref name="Light, 2012">{{Citation | |||
| last1 | |||
| last2 | |||
| last3 | |||
| last4 | |||
| last5 | |||
| last6 | |||
| last7 | |||
| title | |||
| journal = Journal of Internal Medicine | |||
| date | |||
| pmid | |||
| doi | |||
}} | |||
</ref> | |||
<ref name="Montoya, 2018">{{Citation | |||
| last1 | |||
| last2 | |||
| last3 | |||
| last4 | |||
| last5 | |||
| last6 | |||
| last7 | |||
| last8 | |||
| title | |||
| journal = International Journal of Clinical and Experimental Medicine | volume = 11 | issue = 3 | page = 2890-2900 | |||
| date | |||
| pmid | |||
| doi | |||
| url | |||
}} | |||
</ref> | |||
<ref name="Nagy-Szakal, 2017">{{Citation | |||
| last1 | |||
| last2 | |||
| last3 | |||
| last4 | |||
| last5 | |||
| last6 | |||
| last7 | |||
| last8 | |||
| last9 | |||
| last10 | |||
| last11 | |||
| last12 | |||
| last13 | |||
| last14 | |||
| last15 | |||
| last16 | |||
| title | |||
| journal = Microbiome | |||
| date | |||
| pmid | |||
| doi | |||
}} | |||
</ref> | |||
<ref name="Nagy-Szakal, 2018">{{Citation | |||
| last1 | |||
| last2 | |||
| last3 | |||
| last4 | |||
| last5 | |||
| last6 | |||
| last7 | |||
| last8 | |||
| last9 | |||
| last10 | |||
| last11 | |||
| last12 | |||
| last13 | |||
| last14 | |||
| last15 | |||
| last16 | |||
| last17 | |||
| title | |||
| journal = Scientific Reports | |||
| date | |||
| pmid | |||
| doi | |||
}} | |||
</ref> | |||
<ref name="Nov, 2006">{{citation | |||
| author = HHS.gov | |||
| title | |||
| type = Minutes | |||
| date | |||
| url | |||
}}</ref> | |||
<ref name="Spring, 2009">{{citation | |||
| author = HHS.gov | |||
| title | |||
| type = Roster | |||
| date | |||
| url | |||
}}</ref> | |||
<ref name="Strayer, 2012">{{Citation | |||
| last1 | |||
| last2 | |||
| last3 | |||
| last4 | |||
| last5 | |||
| last6 | |||
| last7 | |||
| last8 | |||
| last9 | |||
| last10 | |||
| title | |||
| journal = PLoS One | |||
| date | |||
| pmid | |||
| doi | |||
}} | |||
</ref> | |||
<ref name="Unger, 2017">{{Citation | |||
| last1 | |||
| last2 | |||
| last3 | |||
| last4 | |||
| last5 | |||
| last6 | |||
| last7 | |||
| last8 | |||
| last9 | |||
| last10 | |||
| last11 | |||
| last12 | |||
| last13 | |||
| last14 | |||
| last15 | |||
| last16 | |||
| last17 | |||
| last18 | |||
| last19 | |||
| last20 | |||
| last21 | |||
| last22 | |||
| title | |||
| journal = American Journal of Epidemiology | |||
| date | |||
| pmid | |||
| doi | |||
}} | |||
</ref> | |||
</references> | </references> | ||
Latest revision as of 17:43, April 2, 2023
Lucinda Bateman (Cindy Bateman), MD, is an ME/CFS physician and researcher. She founded and is Chief Medical Officer of the Bateman Horne Center of Excellence for ME/CFS and Fibromyalgia in Salt Lake City, Utah.[1]
Dr. Bateman was one of the authors of the 2011 case definition, International Consensus Criteria,[2] and was one of the experts on the "Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome" that was convened for the 2015 Institute of Medicine report.[3]
Suzanne Vernon, PhD, the Research Liaison at Bateman Horne Center of Excellence works closely with Dr. Bateman on ME/CFS and fibromyalgia research.[4]
Awards[edit | edit source]
- 2016, Rudy Perpich Senior Lectureship Award, presented to a distinguished CFS/FMS scientist, physician or healthcare worker awarded by International Association for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis[5]
Boards and committees[edit | edit source]
CFSAC committee[edit | edit source]
Dr. Bateman was a voting member of the Health and Human Services's Chronic Fatigue Syndrome Advisory Committee for the terms 12/01/05 to 12/01/08[6] & 01/03/06 to 01/03/10[7] and was serving the term 12/13/2017 to Sep 2020 when the committee was dissolved by HHS.[8]
Journal editoral board[edit | edit source]
Dr. Bateman serves on the editorial board of the journal, Fatigue: Biomedicine, Health & Behavior.[9]
ME/CFS Common Data Elements (CDE) Project[edit | edit source]
Member of the Pain Working Group of the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Common Data Element (CDE) Project sponsored by the National Institute of Neurological Disorders and Stroke and the Centers for Disease Control and Prevention.[10]
Advocacy[edit | edit source]
Open letter to The Lancet[edit | edit source]
Two open letters to the editor of The Lancet urged the editor to commission a fully independent review of the PACE trial, which the journal had published in 2011. In 2016, Dr. Bateman, along with 41 colleagues in the ME/CFS field, signed the second letter.
- 10 February 2016, An open letter to The Lancet, again - Virology blog
Editorials[edit | edit source]
- Aug 2019, Editorial: Advances in ME/CFS Research and Clinical Care[11] - (Partial text)
Research studies[edit | edit source]
- 2005, A team approach to treating CFS: Matching best medical practices to phases of illness.[12]
- 2010, Severity of symptom flare after moderate exercise is linked to cytokine activity in chronic fatigue syndrome[13] - (Full Text)
- 2011, Absence of XMRV retrovirus and other murine leukemia virus-related viruses in patients with chronic fatigue syndrome[14] - (Full Text)
- 2011, Evidence for a heritable predisposition to Chronic Fatigue Syndrome[15] - (Full Text)
- 2012, A double-blind, placebo-controlled, randomized, clinical trial of the TLR-3 agonist rintatolimod in severe cases of chronic fatigue syndrome[16] - (Full Text)
- 2012, A Multicenter Blinded Analysis Indicates No Association between Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and either Xenotropic Murine Leukemia Virus-Related Virus or Polytropic Murine Leukemia Virus[17] - (Full Text)
- 2012, Gene expression alterations at baseline and following moderate exercise in patients with Chronic Fatigue Syndrome and Fibromyalgia Syndrome[18] - (Full Text)
- 2013, Differing leukocyte gene expression profiles associated with fatigue in patients with prostate cancer versus chronic fatigue syndrome[19] - (Full Text)
- 2014, No association found between the detection of either xenotropic murine leukemia virus-related virus or polytropic murine leukemia virus and chronic fatigue syndrome in a blinded, multi-site, prospective study by the establishment and use of the SolveCFS BioBank[20] - (Full Text)
- 2015, Findings from a clinical and laboratory database developed for discovery of pathogenic mechanisms in myalgic encephalomyelitis/chronic fatigue syndrome[21] - (Abstract)
- 2015, Chronic fatigue syndrome and co-morbid and consequent conditions: evidence from a multi-site clinical epidemiology study[22] - (Abstract)
- 2015, Distinct plasma immune signatures in ME/CFS are present early in the course of illness[23] - (Full text)
- 2016, Treatment of postural orthostatic tachycardia syndrome and management of myalgic encephalomyelitis/chronic fatigue syndrome following suspected West Nile virus infection[24] - (Abstract)
- 2017, Multi-Site Clinical Assessment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (MCAM): Design and Implementation of a Prospective/Retrospective Rolling Cohort Study[25] - (Abstract)
- 2017, Multi-Site Clinical Assessment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (MCAM): Design and Implementation of a Prospective/Retrospective Rolling Cohort Study[25] - (Abstract)
- 2017, Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome[26] - (Full Text)
- 2018, KPAX002 as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A prospective, randomized trial[27] - (Full Text)
- 2018, Insights into myalgic encephalomyelitis/chronic fatigue syndrome phenotypes through comprehensive metabolomics[28] - (Full Text)
- 2019, Estimating Prevalence, Demographics, and Costs of ME/CFS Using Large Scale Medical Claims Data and Machine Learning[29] - (Full text)
- Aug 2019, Editorial: Advances in ME/CFS Research and Clinical Care[30] - (Full text)
- 2019, Pilot assessment of low NK cell-mediated ADCC and FCGR3A genetics in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): Based on inclusion of family members without ME/CFS as controls, low ADCC is unsuitable as a diagnostic biomarker[31] - (Abstract)
- 2019, Perturbation of effector and regulatory T cell subsets in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)[32] - (Full text)
- 2020, Hemodynamics during the 10-minute NASA Lean Test: evidence of circulatory decompensation in a subset of ME/CFS patients[33] - (Full text)
- 2021, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Essentials of Diagnosis and Management[34] - (Full text)
Clinic location[edit | edit source]
24 S. 1100 E., Suite 205
Salt Lake City, Utah 84102
[[1]]
Talks and interviews[edit | edit source]
- Sep 9, 2014, Can ME/CFS and FM Research Help You Sleep?
- 2015, Spoonie Radio Episode 10 Guest - Dr. Lucinda Bateman - Podcast and Full Text Transcript
- 2016, Simple But Effective Tools for Management of ME/CFS and FM - Lucinda Bateman, MD
- 2016, BHC Wings to Fly - Dr. Bateman
- 2016, 12th International IACFS/ME Biennial Clinical and Research Conference, Emerging Science and Clinical Care, Paper presentation:Synergy Trial for CFS – a phase 2 study of low-dose methylphenidate plus mitochondrial support
- May 3-5, 2018, ME/CFS Canadian Collaborative Team Conference - Speech title: Objective Diagnosis of ME/CFS[35]
- Oct 23, 2021, Clinical Perspective and Impact of Long Covid
Webinars[edit | edit source]
Science to patients / Wetenschap voor patienten
- 2015, 68. Introduction and diagnosis / intriductie en diagnose - Dr. Lucinda Bateman
- 2015, 69. Autoimmunity in ME/cfs / Auto-immuniteit bij ME/cvs - Dr. Lucinda Bateman
- 2015, 70. Neuroinflammation and ME/cfs / Neuro-inflammatie en ME/cvs - Dr. Lucinda Bateman
- 2015, 71. ME/cfs and the Brain/ ME/cvs en de hersenen - Dr. Lucinda Bateman
- 2015, 72. Gene-expression and exercise / gen-expressie en inspanning - Dr. Lucinda Bateman
- 2015, 73. FAQs part 1 / Veel gestelde vragen deel 1 - Dr. Lucinda Bateman
- 2015, 74. FAQs part 2 / Veel gestelde vragen deel 2 - Dr. Lucinda Bateman
Solve ME/CFS Initiative
- Apr 17, 2015 "Will SEID Diagnostic Criteria Improve Diagnosis and Treatment?"
- Nov 14, 2014 "Can ME CFS and Fibromyalgia Research Help You Sleep?"
Blog posts[edit | edit source]
- October 17, 2016, Pearls of Wisdom from an ME/CFS Physician, part 1
- October 17, 2016, Pearls of Wisdom from an ME/CFS Physician, part 2
- October 17, 2016, Pearls of Wisdom from a CFS Physician, part 3
Online presence[edit | edit source]
See also[edit | edit source]
Learn more[edit | edit source]
References[edit | edit source]
- ↑ https://batemanhornecenter.org/
- ↑ Carruthers, Bruce M.; van de Sande, Marjorie I.; De Meirleir, Kenny L.; Klimas, Nancy G.; Broderick, Gordon; Mitchell, Terry; Staines, Donald; Powles, A.C. Peter; Speight, Nigel; Vallings, Rosamund; Bateman, Lucinda; Baumgarten-Austrheim, Barbara; Bell, David; Carlo-Stella, Nicoletta; Chia, John; Darragh, Austin; Jo, Daehyun; Lewis, Donald; Light, Alan; Marshall-Gradisnik, Sonya; Mena, Ismael; Mikovits, Judy; Miwa, Kunihisa; Murovska, Modra; Pall, Martin; Stevens, Staci (August 22, 2011). "Myalgic encephalomyelitis: International Consensus Criteria". Journal of Internal Medicine. 270 (4): 327–338. doi:10.1111/j.1365-2796.2011.02428.x. ISSN 0954-6820. PMC 3427890. PMID 21777306.
- ↑ Syndrome, Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue; Populations, Board on the Health of Select; Medicine, Institute of (February 10, 2015). Biographical Sketches of Committee Members, Consultants, and Staff. National Academies Press (US).
- ↑ https://batemanhornecenter.org/suzanne-d-vernon-phd/
- ↑ "IACFS/ME Awardees". IACFS/ME. Retrieved April 23, 2020.
- ↑ HHS.gov (2006), Nov 20 & 21, 2006 CFSAC Meeting (PDF) (Minutes)
- ↑ HHS.gov (2009), May 27 & 28, 2009 CFSAC Meeting (PDF) (Roster)
- ↑ https://www.hhs.gov/ash/advisory-committees/cfsac/about-cfsac/roster/index.html
- ↑ "Fatigue: Biomedicine, Health & Behavior". tandfonline.com. Retrieved November 1, 2019.
- ↑ "Complete Myalgic Encephalomyelitis/Chronic Fatigue Syndrome CDE Roster". NIH. Retrieved October 11, 2019.
- ↑ Friedman, Kenneth; Bateman, Lucinda; Bested, Alison C.; Nahle, Zaher (August 2019). "Editorial: Advances in ME/CFS Research and Clinical Care". Frontiers in Pediatrics. doi:10.3389/fped.2019.00370.
- ↑ Fennell, P. A., & Bateman, L. (2005). "A team approach to treating CFS: Matching best medical practices to phases of illness." CFS Research Review, Summer.
- ↑ White, A.T., Light, A.R., Hughen, R.W., Bateman, L., Martins, T.B., Hill, H.R., and Light, K.C. (2010) Severity of symptom flare after moderate exercise is linked to cytokine activity in chronic fatigue syndrome. Psychophysiology, 47(4):615-24. doi: 10.1111./j.1469-8986.2010.00978.x
- ↑ Shin, Clifford H.; Bateman, Lucinda; Schlaberg, Robert; Bunker, Ashley M.; Leonard, Christopher J.; Hughen, Ronald W.; Light, Alan R.; Light, Kathleen C; Singh, Ila R. (July 2011). "Absence of XMRV retrovirus and other murine leukemia virus-related viruses in patients with chronic fatigue syndrome". Journal of Virology. 85 (14): 7195–202. doi:10.1128/JVI.00693-11.
- ↑ Albright, Frederick; Light, Kathleen; Light, Alan; Bateman, Lucinda; Cannon-Albright, Lisa A (2011), "Evidence for a heritable predisposition to Chronic Fatigue Syndrome", BMC Neurology, 11 (62), doi:10.1186/1471-2377-11-62
- ↑ Strayer, DR; Carter, WA; Stouch, BC; Stevens, SR; Bateman, L; Cimoch, PJ; Lapp, CW; Peterson, DL; Chronic Fatigue Syndrome AMP-516 Study Group; Mitchell, WM (2012), "A double-blind, placebo-controlled, randomized, clinical trial of the TLR-3 agonist rintatolimod in severe cases of chronic fatigue syndrome.", PLoS One, 7 (3): e31334, doi:10.1371/journal.pone.0031334, PMID 22431963
- ↑ Alter, Harvey J.; Mikovits, Judy A.; Switzer, William M.; Ruscetti, Francis W.; Lo, Shyh-Ching; Klimas, Nancy; Komaroff, Anthony L.; Montoya, Jose G.; Bateman, Lucinda; Levine, Susan; Peterson, Daniel; Levin, Bruce; Hanson, Maureen R.; Genfi, Afia; Bhat, Meera; Zheng, HaoQiang; Wang, Richard; Li, Bingjie; Hung, Guo-Chiuan; Lee, Li Ling; Sameroff, Stephen; Heneine, Walid; Coffin, John; Hornig, Mady; Lipkin, W. Ian (2012), "A Multicenter Blinded Analysis Indicates No Association between Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and either Xenotropic Murine Leukemia Virus-Related Virus or Polytropic Murine Leukemia Virus", mBio, 3 (5): e00266–12, doi:10.1128/mBio.00266-12
- ↑ Light, Alan R; Bateman, Lucinda; Jo, Daehyun; Hughen, RW; Vanhaitsma, TA; White, AT; Light, Kathleen (2012), "Gene expression alterations at baseline and following moderate exercise in patients with Chronic Fatigue Syndrome and Fibromyalgia Syndrome", Journal of Internal Medicine, 271 (1): 64-81, doi:10.1111/j.1365-2796.2011.02405.x
- ↑ Light, Kathleen C.; Agarwal, Neeraj; Iacob, Eli; White, Andrea T.; Kinney, Anita Y.; VanHaitsma, Timothy A.; Aizad, Hannah; Hughen, Ronald W.; Bateman, Lucinda (December 2013). "Differing leukocyte gene expression profiles associated with fatigue in patients with prostate cancer versus chronic fatigue syndrome". Psychoneuroendocrinology. 38 (12): 2983–2995. doi:10.1016/j.psyneuen.2013.08.008. PMC 3848711. PMID 24054763.
- ↑ Irlbeck, David M.; Vernon, Suzanne D.; McCleary, K. Kimberly; Bateman, Lucinda; Klimas, Nancy G.; Lapp, Charles W.; Peterson, Daniel L.; Brown, James R.; Remlinger, Katja S.; Wilfret, David A.; Gerondelis, Peter (2014). "No association found between the detection of either xenotropic murine leukemia virus-related virus or polytropic murine leukemia virus and chronic fatigue syndrome in a blinded, multi-site, prospective study by the establishment and use of the SolveCFS BioBank". BMC Research Notes. 7: 461. doi:10.1186/1756-0500-7-461.
- ↑ Klimas, N.G.; Ironson, G.; Carter, A.; Balbin, E.; Bateman, L.; Felsenstein, D.; Levine, S.; Peterson, D.; Chiu, K.; Allen, A.; Cunningham, K.; Gottschalk, C.G.; Fletcher, M; Hornig, M.; Canning, C.; Komaroff, A.L. (2015), "Findings from a clinical and laboratory database developed for discovery of pathogenic mechanisms in myalgic encephalomyelitis/chronic fatigue syndrome", Fatigue: Biomedicine, Health & Behavior, 3 (2): 75-96, doi:10.1080/21641846.2015.1023652
- ↑ Bateman, L.; Darakjy, S.; Klimas, N.; Peterson, D.; Levine, S.M.; Allen, A.; Carlson, S.A.; Balbin, E.G.; Gottschalk, G.; March, D. (2015), "Chronic fatigue syndrome and co-morbid and consequent conditions: evidence from a multi-site clinical epidemiology study", Fatigue: Biomedicine, Health & Behavior, 3 (1): 1-15, doi:10.1080/21641846.2014.978109
- ↑ Hornig, M; Montoya, JG; Klimas, NG; Levine, SM; Felsenstein, D; Bateman, L; Peterson, DL; Gottschalk, CG; Schultz, AF; Che, X; Eddy, ML; Komaroff, AL; Lipkin, WI (2015). "Distinct plasma immune signatures in ME/CFS are present early in the course of illness". Science Advances. 1 (1). doi:10.1126/sciadv.1400121.
- ↑ Baldwin, Nicole L.; Murray, Kristy O.; Garcia, Melissa N.; Bateman, Lucinda (2016), "Treatment of postural orthostatic tachycardia syndrome and management of myalgic encephalomyelitis/chronic fatigue syndrome following suspected West Nile virus infection", Fatigue: Biomedicine, Health & Behavior, 4 (4): 226-236, doi:10.1080/21641846.2016.1247971
- ↑ 25.0 25.1 Unger, Elizabeth R.; Lin, Jin-Mann S.; Tian, Hao; Natelson, Benjamin H; Lange, Gudrun; Vu, Diana; Blate, Michelle; Klimas, Nancy G.; Balbin, Elizabeth G.; Bateman, Lucinda; Allen, Ali; Lapp, Charles W.; Springs, Wendy; Kogelnik, Andreas M.; Phan, Catrina C.; Danver, Joan; Podell, Richard N.; Fitzpatrick, Trisha; Peterson, Daniel L.; Gottschalk, C. Gunnar; Rajeevan, Mangalathu S.; MCAM Study Group (2017), "Multi-Site Clinical Assessment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (MCAM): Design and Implementation of a Prospective/Retrospective Rolling Cohort Study.", American Journal of Epidemiology, 1–10, doi:10.1093/aje/kwx029
- ↑ Nagy-Szakal, Dorottya; Williams, Brent L.; Mishra, Nischay; Che, Xiaoyu; Lee, Bohyun; Bateman, Lucinda; Klimas, Nancy G.; Komaroff, Anthony L.; Levine, Susan; Montoya, Jose G.; Peterson, Daniel L.; Ramanan, Devi; Jain, Komal; Eddy, Meredith L.; Hornig, Mady; Lipkin, W. Ian (2017), "Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome", Microbiome, 5 (44), doi:10.1186/s40168-017-0261-y
- ↑ Montoya, Jose G; Anderson, Jill N; Adolphs, Danya L; Bateman, Lucinda; Klimas, Nancy; Levine, Susan M; Garvert, Donn W; Kaiser, Jon D (2018), "KPAX002 as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A prospective, randomized trial" (PDF), International Journal of Clinical and Experimental Medicine, 11 (3): 2890-2900
- ↑ Nagy-Szakal, Dorottya; Barupal, Dinesh K.; Lee, Bohyun; Che, Xiaoyu; Williams, Brent L.; Kahn, Ellie J. R.; Ukaigwe, Joy E.; Bateman, Lucinda; Klimas, Nancy G.; Komaroff, Anthony L.; Levine, Susan; Montoya, Jose G.; Peterson, Daniel L.; Levin, Bruce; Hornig, Mady; Fiehn, Oliver; Lipkin, W. Ian (2018), "Insights into myalgic encephalomyelitis/chronic fatigue syndrome phenotypes through comprehensive metabolomics", Scientific Reports, 8 (1): 10056, doi:10.1038/s41598-018-28477-9
- ↑ Proskauer, Charmian; Rowe, Peter C.; Lapp, Charles W.; DeMaria, Alfred Jr; Bateman, Lucinda; Attewell, John R.; Proskauer, Daniel; Kiernicki, David J.; Adebayo, Seyi (2019). "Estimating Prevalence, Demographics, and Costs of ME/CFS Using Large Scale Medical Claims Data and Machine Learning". Frontiers in Pediatrics. 6. doi:10.3389/fped.2018.00412. ISSN 2296-2360. PMID 30671425.
- ↑ Friedman, Kenneth; Bateman, Lucinda; Bested, Alison C.; Nahle, Zaher (August 2019). "Editorial: Advances in ME/CFS Research and Clinical Care". Frontiers in Pediatrics. doi:10.3389/fped.2019.00370.
- ↑ Sung, Alexander P.; Tang, Jennifer J-J; Guglielmo, Michael J; Smith-Gagen, Julie; Bateman, Lucinda; Redelman, Doug D.; Hudig, Dorothy (December 27, 2019). "Pilot assessment of low NK cell-mediated ADCC and FCGR3A genetics in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): Based on inclusion of family members without ME/CFS as controls, low ADCC is unsuitable as a diagnostic biomarker". MedRxIV. doi:10.1101/2019.12.20.19015438.
- ↑ Karhan, Ece; Gunter, Courtney L; Ravanmehr, Vida; Horne, Meghan; Kozhaya, Lina; Renzullo, Stephanie; Placek, Lindsey; George, Joshy; Robinson, Peter N; Vernon, Suzanne D.; Bateman, Lucinda; Unutmaz, Derya (December 26, 2019). "Perturbation of effector and regulatory T cell subsets in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)". biorxiv. doi:10.1101/2019.12.23.887505.
- ↑ Lee, Jihyun; Vernon, Suzanne D.; Jeys, Patricia; Ali, Weam; Campos, Andrea; Unutmaz, Derya; Yellman, Brayden; Bateman, Lucinda (December 2020). "Hemodynamics during the 10-minute NASA Lean Test: evidence of circulatory decompensation in a subset of ME/CFS patients". Journal of Translational Medicine. 18 (1): 314. doi:10.1186/s12967-020-02481-y. ISSN 1479-5876. PMC 7429890. PMID 32799889.
- ↑ Bateman, Lucinda; Bested, Alison C.; Bonilla, Hector F.; Chheda, Bela V.; Chu, Lily; Curtin, Jennifer M.; Dempsey, Tania T.; Dimmock, Mary E.; Dowell, Theresa G.; Felsenstein, Donna; Kaufman, David L. (November 1, 2021). "Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Essentials of Diagnosis and Management". Mayo Clinic Proceedings. 96 (11): 2861–2878. doi:10.1016/j.mayocp.2021.07.004. ISSN 0025-6196.
- ↑ "ME/CFS Canadian Collaborative Team Conference program" (PDF). Retrieved March 6, 2019.